After the first intraspinal partial resection, the diagnosis of MMNST was established
Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials
Trump announces major deal to lower cost of weight loss medications The Trump administration announced new agreements with Eli Lilly, maker of Zepbound, and Novo Nordisk, which makes Wegovy, to lower starter-dose costs to $350 a month
and Yaoling Biotechnology (Guangzhou) Co., Ltd
Jones MG, Goodwin CS, Amjad S, Chalmers RA
2025 Updates: Whats New in the GLP-1 Space Recently Approved Medications and Indications Recent regulatory activity has expanded the therapeutic scope of existing GLP 1 medications